562 Benefit from atezolizumab in patients with a poor prognostic ovarian cancer in first-line setting: IMAGYN-050 trial
Year: 2024
Type: article
Authors: Benoit You, Charles Anderson, Sabrina Chiara Cecere, Aurore Carrot, Tashanna Myers, Florian Heitz, Sharma Sudarshan, Fatih Selçukbiricik, Carol Aghajanian, Josefin Fernebro, Stephanie Blank, Maria Elena Laudani, Premal Thaker, Mayu Yunokawa, Lynday willmott, Yvette He, Charles Landen, Yvonne G. Lin, Jesús alarcón, Kathleen N. Moore
Institutions: Hospices Civils de Lyon, Centre pour l'innovation en cancérologie de Lyon, University of Colorado Health, University of Colorado Anschutz, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Université de Lyon, Baystate Health, Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe, Kliniken Essen-Mitte, Koç University, Memorial Sloan Kettering Cancer Center, Karolinska University Hospital, Icahn School of Medicine at Mount Sinai, University of Turin, Washington University in St. Louis, The Cancer Institute Hospital, Japanese Foundation For Cancer Research, University of Alabama at Birmingham, UAB Medicine, Genentech, Hospital Universitario Son Espases, University of Oklahoma Health Sciences Center
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4392633171